Skip to main content


Figure 4 | Diabetology & Metabolic Syndrome

Figure 4

From: A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy

Figure 4

Sensitivity analysis across different meta-analysis models. A) HbA1c, weighted mean difference, B) weight (kg), weighted mean difference, C) hypoglycaemia odds ratio; DPP-4, dipeptidyl peptidase-4 inhibitors; direct, direct meta-analysis; FE, fixed-effect; GLP-1, glucagon-like peptide-1 analogues; NMA, network meta-analysis; OR, odds ratio; RE, random-effects; SGLT2, sodium glucose co-transporter 2 inhibitors; WMD, weighted mean difference.

Back to article page